ASTEX PHARMACEUTICALS, INC Share-based Payment Arrangement, Expense
ASTEX PHARMACEUTICALS, INC reported Share-based Payment Arrangement, Expense of $841.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for the quarter ending 2013-06-30 was $841.00K, a 3.83% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for the quarter ending 2013-03-31 was $1.04M, a 36.60% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for the quarter ending 2012-12-31 was $624.00K, a 18.96% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $885.00K, a 3.15% increase year-over-year.
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for fiscal 2012 was $3.08M, a 0.03% increase from fiscal 2011.
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for fiscal 2011 was $3.08M, a 115.29% increase from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC share-based payment arrangement, expense for fiscal 2010 was $1.43M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2013-06-30 | $841.00K 10-Q · filed 2013-08-09 | $1.89M 10-Q · filed 2013-08-09 | $2.51M derived: sum of 3 quarters · filed 2013-08-09 | $3.40M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $1.04M 10-Q · filed 2013-05-10 | $1.67M derived: sum of 2 quarters · filed 2013-05-10 | $2.55M derived: sum of 3 quarters · filed 2013-05-10 | $3.36M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.51M derived: sum of 2 quarters · filed 2013-03-18 | $2.32M derived: sum of 3 quarters · filed 2013-08-09 | $3.08M 10-K · filed 2013-03-18 |
| 2012-09-30 | $885.00K 10-Q · filed 2012-11-09 | $1.70M derived: sum of 2 quarters · filed 2013-08-09 | $2.46M 10-Q · filed 2012-11-09 | $3.23M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $810.00K 10-Q · filed 2013-08-09 | $1.57M 10-Q · filed 2013-08-09 | $2.35M derived: sum of 3 quarters · filed 2013-08-09 | $3.20M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $765.00K 10-Q · filed 2013-05-10 | $1.53M derived: sum of 2 quarters · filed 2013-05-10 | $2.39M derived: sum of 3 quarters · filed 2013-05-10 | $3.14M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $770.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.63M derived: sum of 2 quarters · filed 2013-03-18 | $2.37M derived: sum of 3 quarters · filed 2013-03-18 | $3.08M 10-K · filed 2013-03-18 |
| 2011-09-30 | $858.00K 10-Q · filed 2012-11-09 | $1.60M derived: sum of 2 quarters · filed 2012-11-09 | $2.31M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $744.00K 10-Q · filed 2012-08-09 | $1.46M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $1.43M 10-K · filed 2013-03-18 |